Lepu Medical Technology (300003.SZ) subsidiary Minwei Biotechnology MWN109 tablets received the drug clinical trial approval notice.

China Finance and Economics App News, Luopu Medical (300003.SZ) announced that its controlling subsidiary Shanghai Minwei Biotechnology Co., Ltd. ("Minwei Biotech") has received the "Notice of Approval for Drug Clinical Trial" issued by the National Medical Products Administration (NMPA). The clinical trial application for MWN109 tablets filed by Minwei Biotech has been approved.